Latest Antiviral drug Stories

One Third of Surveyed Specialists in the EU5 were Unable to Cite Any New Therapy in Development for HCV, According to a New Report from BioTrends Research Group EXTON, Pa., June 11, 2013 /PRNewswire/ -- BioTrends Research Group, one of the world's leading research and advisory firms for specialized biopharmaceutical issues, finds in their TreatmentTrends(®): Hepatitis C Virus (EU) report, that surveyed gastroenterologists and hepatologists in Spain and France are more likely to be...

DOYLESTOWN, Pa., June 5, 2013 /PRNewswire/ -- Novira Therapeutics Inc., today announced the expansion of its senior management team with the appointment of Klaus Klumpp, Ph.D., as vice president, discovery research. Dr. Klumpp will build an internal virology team focused on the hepatitis B virus (HBV) and will oversee biology research at Novira. "The addition of Klaus is an important step in the growth of our company as we transition from a discovery stage company into a development...

Expansion of Therapies Offering Benefits Over Current Standard of Care Will Drive Growth Despite Price Controls in Market, According to a New Report from Decision Resources BURLINGTON, Mass., June 4, 2013 /PRNewswire/ -- Decision Resources, one of the world's leading research and advisory firms for pharmaceutical and healthcare issues, forecasts that, from 2012 to 2017, the hepatitis C virus (HCV) market in Turkey will more than triple, reaching $275 million in 2017. The Emerging...

Brett Smith for redOrbit.com - Your Universe Online Patients with a severe or deadly case of the flu are often prescribed the antiviral drug Tamiflu; but there are no additional benefits to taking a double dose of the drug, according to a new study from researchers at the South East Asia Infectious Diseases Clinical Research Network (SEAICRN). The study’s findings, which were published in the British Medical Journal (BMJ), conflict with the recommendations of some experts who have...

Lawrence LeBlond for redOrbit.com - Your Universe Online Last week the United Nations reported that the 2013 H7N9 bird flu outbreak was under control in China, stating that closures of live poultry markets likely helped in the decline of cases seen since the beginning of May. The report was welcoming news for a disease that has infected more than 130 people and killed at least 36 since first being detected at the end of March. But now, on a darker note, a newly released paper is...

MILFORD, Mass., May 23, 2013 /PRNewswire/ -- Spring Bank Pharmaceuticals, Inc., a biopharmaceutical company developing innovative medicines for the treatment of viral infections, today announced that it has initiated dosing in a Phase I study of SB 9200, its investigational, once daily, oral therapy for the treatment of HCV infection. This study will be conducted in healthy, HCV-infected patients and is designed to assess both the safety and antiviral efficacy of SB 9200. SB 9200 is a...

May 23, 2013, is Hepatitis B and C Testing and Awareness Day in the U.S. House of Representatives. ALEXANDRIA, Va., May 22, 2013 /PRNewswire/ -- Viral hepatitis is an asymptomatic disease affecting more than 5.3 million Americans. More than 75 percent of those with hepatitis C are unaware they have the virus. Hepatitis B and C Testing and Awareness Day in the U.S. House of Representatives will take place at 10:00 am - 2:00 pm in the Rayburn Foyer of the Rayburn House Office...

Lawrence LeBlond for redOrbit.com - Your Universe Online Herpes is an infectious disease that affects more than 24 million people in the United States alone, according to a recent report by the US Centers for Disease Control and Prevention (CDC). Now, researchers have identified a class of immune cells that exist in genital skin and mucosa that may play a role in developing a vaccine to prevent one of the most common sexually transmitted infections (STIs) in America. These immune cells,...

Scientists show potential impact of therapy in reducing transmission in UK, Canada and Australia Around 150 million people globally are chronically infected with the hepatitis C virus (HCV) – a major cause of liver disease and the fastest growing cause of liver transplantation and liver cancer. 1 New prevention strategies are urgently required as people are continuing to be infected with HCV. Findings, published in Hepatology, reveal the impact of a new antiviral treatment that could...

University of Washington Erasmus virus resets cells' genes and causes breathing distress and kidney failure A new virus that causes severe breathing distress and kidney failure elicits a distinctive airway cell response to allow it to multiply. Scientists studying the Human Coronavirus-Erasmus Medical Center, which first appeared April 2012 in the Middle East, have discovered helpful details about its stronghold tactics. Their findings predict that certain currently available...